Response Surface Pathway Design With Two Interventional- and One Response Variable in Estimating Minimum Efficacy Dose
Randomized Two-dimensional Between-patient Response Surface Pathway Design With Two Interventional- and One Response Variable in Estimating Minimum Efficacy Dose of Osteopathic Manual Therapy in Treatment of Gastroesophageal Reflux Disease
1 other identifier
interventional
15
0 countries
N/A
Brief Summary
Response Surface Pathway (RSP) design was previously developed for dose-finding studies with one interventional and one response variable, but RSP to higher dimensions is requested. The aim of this study is to introduce and evaluate the RSP design with two interventional and one response variable exemplified by estimating Minimum Efficacy Dose (MED) of Osteopathic Manual Therapy (OMT) in treatment of gastroesophageal reflux disease (GERD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2016
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 28, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 24, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 14, 2017
CompletedFirst Submitted
Initial submission to the registry
June 13, 2018
CompletedFirst Posted
Study publicly available on registry
June 26, 2018
CompletedJune 26, 2018
June 1, 2018
7 months
June 13, 2018
June 22, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percent reduction in sum of the five GERD score from baseline.
The five GERD variables recorded at baseline and one week after the last treatment were degrees of "Heartburn", "Chest pain", "Acid in mouth", "Epigastric pain" and "Thoracic pain", each recorded on a 10 cm VAS. The response variables were percent reduction in sum of the five GERD variables from baseline.
One week after last OMT
Study Arms (2)
Number of Osteopatic Manual Therapy
EXPERIMENTALIntervention: OMT. Osteopatic Manual treatment consisting of Thoracic spine, Diaphragm mobilisation, Traction of the cardia and posture correction.
Interval in days between each OMT
EXPERIMENTALIntervention: OMT. The time between each OMT's is calculated by the study design. Each OMT intervantion consists of Thoracic spine and Diaphragm mobilisation, Traction of the cardia and Posture correction.
Interventions
OMT consisting of following interventions; thoracic spine and diaphragm mobilisation, traction of the cardia and posture correction.
Eligibility Criteria
You may qualify if:
- Clinical diagnosed Gastroesophigual Reflux Disease
- Known effect of anti-reflux medication
You may not qualify if:
- Hiatus hernia ≥5 cm
- gastric ulcer
- cancer
- uncontrolled bacterial, viral, fungal or parasite infection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Meddoclead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stig E Larsen, PhD
Norwegian Univesity of Life Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 13, 2018
First Posted
June 26, 2018
Study Start
September 28, 2016
Primary Completion
April 24, 2017
Study Completion
October 14, 2017
Last Updated
June 26, 2018
Record last verified: 2018-06